Infectious Disease Clinics of North America

Papers
(The TQCC of Infectious Disease Clinics of North America is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Forthcoming Issues177
Copyright153
COVID-19 Infection83
Advances in the Management of HIV83
Contributors80
Contributors69
Infectious Pulmonary Diseases58
Copyright54
Forthcoming Issues50
Contributors49
Challenges in Managing Gonorrhea and New Advances in Prevention47
Contributors43
Forthcoming Issues39
Contributors38
Climate Change and Medical Mycology36
The New Medical Mycology34
Contents33
Occupational Health Update31
Forthcoming Issues31
After the COVID-19 Crisis: Update on Complex Infectious Diseases Issues in the Intensive Care Unit30
Contents30
Recurrent UTI in Women–Risk Factors and Management28
Contents27
Copyright27
Contributors23
Prevention of Mycobacterium tuberculosis Transmission in Health Care Settings22
Pharmacologic Treatment and Management of Coronavirus Disease 201922
Advances in HIV Management During Pregnancy and Infant Feeding22
Operationalization of Status Neutral Human Immunodeficiency Virus Care for Criminal-Legal Involved Populations21
Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics20
Surgical Site Infections18
Urinary Tract Infection in Male Patients17
Antimicrobial Resistance in Organ Transplant Recipients16
Supportive Care in Patients with Critical Coronavirus Disease 201916
Nervous System Lyme Disease–Facts and Fallacies16
Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation16
Sexual Transmission of Viral Hepatitis16
Laboratory Diagnosis for SARS-CoV-2 Infection16
Severe Clostridioides difficile Infection in the Intensive Care Unit—Medical and Surgical Management14
Reducing Treatment of Asymptomatic Bacteriuria14
Themes and Challenges in Managing Musculoskeletal Infections13
Antifungal Susceptibility Testing and Identification13
Antifungals in Clinical Use and the Pipeline12
Vancomycin-Resistant Enterococci12
Behavioral Strategies in Diagnostic Stewardship12
Next-Generation Coronavirus Disease 2019 Vaccines12
Adult Long Coronavirus Disease 201911
Considering Patient, Family, and Provider Goals and Expectations in a Rapidly Changing Clinical Context: A Framework for Antimicrobial Stewardship at the End of Life11
HIV Pre-Exposure Prophylaxis11
Pharmacologic Treatment and Management of Coronavirus Disease 201911
Powassan Virus Encephalitis11
Sexually Transmitted Infections10
Antimicrobial Stewardship in Immunocompromised Patients10
The Role of the Infectious Disease Consultation in Lyme Disease10
Health Care–Acquired Infections in Low- and Middle-Income Countries and the Role of Infection Prevention and Control10
Forthcoming Issues10
Behind Every Great Infection Prevention Program is a Great Microbiology Laboratory10
Management of Unique Pneumonias Seen in the Intensive Care Unit9
Copyright9
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children9
Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management8
Contents8
Infections in Older Adults8
Pediatric Infections in the Time of COVID-198
Advances in the Management of HIV8
Vaccine-Preventable Diseases in Older Adults7
Immunization of Solid Organ Transplant Candidates and Recipients7
COVID-19: Where We Are, Where We Need to Be7
The Role of Biomarkers in the Diagnosis and Management of Pneumonia7
Respiratory Tract Infections in the Postpandemic Era: A Return to Basics and Call to Action7
Forthcoming Issues7
Contributors6
Mucormycosis6
Copyright6
Preface6
Radiographic Imaging of Community-Acquired Pneumonia6
Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation6
0.074319839477539